A bstract. The pattern of episodic gonadotropin release was studied in 15 normal female volunteers during the luteal phase ofthe menstrual cycle with 24 h of blood sampling for follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels at 10-min intervals. Six subjects (two in the early, two in the mid-, and two in the late luteal phase) also had each of these specimens processed for progesterone levels.
Introduction
The corpus luteum (CL)' is an atypical endocrine organ whose short life-span appears to be "programmed" and only partly influenced by external factors. This functional feature is present in greater or lesser extent in all species (1) and the contribution of hormonal factors upon CL activity has not yet been precisely defined. Although luteinizing hormone (LH) is considered to be a luteotropic agent in the human and the subhuman primate, the exact role of LH in the formation, support, and demise of the CL is still controversial (2) . Moreover, the episodic release of gonadotropins in the human is continuously modified across the menstrual cycle. Although it was previously established (3, 4) that LH pulses are less frequent and of larger amplitude in the luteal phase than in the follicular phase, little is known of the spectrum ofthe modifications of these parameters in normal subjects, the precise timing of their occurrence, and the gonadal effects of this modulation of the pituitary signal. This study was designed to explore the pattern ofgonadotropin and progesterone (P) secretion across the luteal phase, analyze the modulation of LH pulse amplitude and frequency, and examine the effect of these changes upon the secretory activity of the human CL.
Methods 15 paid female volunteers participated in the study. Each subject had a history of regular 27-32-d menstrual cycles and body weight± 15% of average (5) . The volunteers were not involved in intensive physical exercise and were not receiving any medications. On physical examination no evidence of hirsutism, galactorrhea, or genital abnormalities was noticed. Plasma prolactin levels were <15 ng/ml in each, and normal luteal function was documented in the previous menstrual cycle by basal body temperature charts and mid-luteal phase P levels > 6 ng/ml.
Daily blood samples were obtained for one complete menstrual cycle and were processed for the determination of gonadotropins, estradiol (E2), and P levels. On one day of the luteal phase of this cycle, each subject was admitted to the Clinical Research Center ofthe Massachusetts General Hospital and 3 ml blood samples were withdrawn at 10-min intervals for 24 consecutive hours. During the 24-h study, five additional plasma samples were drawn at 0, 6, 12, 18, and 24 h for the determination of E2 and P. Five subjects were studied in the early luteal phase (ELP, days [1] [2] [3] [4] post LH mid-cycle surge), five in the mid-luteal phase (MLP, days 5-9 post LH mid-cycle surge), and five in the late luteal phase (LLP, days 10-14 post LH mid-cycle surge). All samples from the 24-h studies were processed for LH and follicle-stimulating hormone (FSH) determinations. Each plasma sample from six ofthe 24-h studies (Subjects A and B in the ELP, C and D in the MLP, and E and F in the LLP) was also assayed for P.
All samples from each subject (daily samples and 24-h study) were run in the same double antibody radioimmunoassay (RIA) for LH and FSH determinations. The LH and FSH antisera were purchased from Serono-Biodata Diagnostics Division (Rome, Italy). Human chorionic gonadotropin (hCG) was labelled and used as a tracer in the LH assay.
Values were expressed as equivalents of the 2nd International Reference Preparation-human menopausal gonadotropin (mIU/ml). The sensitivity (95% confidence limit) of the LH and FSH assays varied between 0.8 and 1.6 mIU/ml of plasma. The precision of the gonadotropin assays was estimated at 20, 50, and 80% (B/Bo) displacement of the standard curve. The quality control characteristics of the gonadotropin assays reported herein are shown in Table I . P concentrations were estimated by RIA. All plasma samples from each 24-h study were processed within the same assay. Several standard curves and quality controls were interspersed within each assay to monitor precision. Separation of bound/free was carried out with charcoal in two successive steps, each including half of the assay samples in order to contain the time of the charcoal addition procedure to within 25-30 min. The intrassay and interassay coefficient of variation for the P assay are shown in Table I . To observe the effect of different bound/ free separation procedures, one of the 24-h studies was processed twice for P. the second time utilizing Staphylococcal Protein A (6) as a separation method. The result of the two P assays were almost perfectly superimposable and no differences in the pattern of secretion were identified with the use of a different separation procedure (data not shown).
Several algorithms exist in the literature for computer-assisted pulse analysis (4, 7, 8) . All of these methods of analysis are essentially threshold detectors, i.e., a hormone fluctuation is considered a pulse when its amplitude exceeds a predetermined value. For our study we chose to apply the Santen and Bardin (4) approach because of the experience accumulated with this method by other investigators, as well as for its ease and simplicity of use. We also reanalyzed our data with the Pulsar program by Merriam and Wachter (7) and found no significant difference in trends and correlations, although the actual number ofpulses detected varied modestly. We implemented a slightly modified version of the Santen and Bardin program on a VAX 11/780 computer (Digital Equipment Corp., Marlboro, MA), where LH pulsations were defined as increments of plasma levels > I mIU/ml which exceeded the previous nadir by 20% or more. The LH interpulse interval represents the time between two consecutive LH pulses. The amplitude of a pulse was defined as the difference between the highest value in the pulse and the preceding nadir. Cross-correlation analysis (9) was utilized to define the temporal relationship between LH, FSH, and P data series during each 24-h study. A P value < 0.05 was assumed as significance level for the cross-correlation. Two-tailed t statistics and linear correlation analysis were utilized as indicated. 
Results
All the subjects studied had endocrinologically normal menstrual cycles with mid-lutelal P levels which exceeded 9 ng/ml and a luteal phase duration > 13 d. Gonadotropins (Table II) . Mean LH levels decreased from 21.5±5.2 mIU/ml (mean±SD) in the ELP to 6.9±1.9 mIU/ml in the MLP (P < 0.01) and 6.8±1.2 mIU/ml in the LLP (P < 0.01 between ELP and LLP but NS between MLP and LLP). The frequency of LH pulsatile discharge changed across the luteal phase as the mean LH interpulse interval progressively increased from 99±20 min in the ELP (15.2 pulses/24 h) to 162±33 min in the MLP (9.2 pulses/24 h) and 173±20 min in the LLP (8.4 pulses/24 h). This difference in the mean LH interpulse interval achieved significance between the ELP and the MLP (P < 0.05) and the LLP (P < 0.01), but not between the MLP and the LLP. However, the mean LH interpulse interval was positively correlated (r = 0.80, P < 0.001) with the day of the luteal phase ( Fig. 1 ). On the other hand, no significant correlation existed between the mean P levels on the day of the 24-h study and the mean LH interpulse interval.
The mean amplitude of LH pulses progressively declined from 12.3±2.2 mIU/ml in the ELP to 10.7±4.6 mIU/ml in the MLP and 8.6±3.4 mIU/ml in the LLP. Although a clear trend was evident, none of these changes was statistically significant. In the same 24-h period, heterogeneous LH pulses could be identified ( Fig. 2 ) and divided arbitrarily into pulses of <5 mIU/ ml and >5 mIU/ml amplitude. When this was done the mean±SD amplitude ofthe smaller pulses and larger pulses was 2.3±1.0 and 16.9±4.7 mIU/ml, respectively (P < 0.001). The incidence ( Fig. 3 ) of smaller (<5 mIU/ml amplitude) LH pulses increased from an average of 19% of the total pulses observed in the ELP to 52% in the MLP, and then declined slightly in the LLP (45%). A bimodal fashion in the distribution of LH pulse amplitude was present in the MLP, when 52% of LH pulses were <5 mIU/ml, 17% had an amplitude of 5-15 mIU/ ml, and 30% were > 15 mIU/ml. The increase in the incidence of <5 mIU/ml LH pulses and the decrement of 5-15 mIU/ml LH pulses was significant (P < 0.05) between the ELP and the MLP (Fig. 3) . The incidence ofsmaller LH pulses was positively correlated (r = 0.63, P < 0.01) to plasma P concentrations on the day of the study ( Fig. 1 ), but not to the day of the luteal phase in which the 24-h study was executed.
The mean FSH plasma levels decreased from 8.5±5.4 to 5.8±1.2 mIU/ml in the MLP and 4.4±2.2 mIU/ml in the LLP.
None of these changes was statistically significant. Although the direct identification of FSH pulses was hampered by the small amplitude of its fluctuations, a significantly (P < 0.05) positive cross-correlation existed between the LH and FSH data series from the pulsation studies of each subject. The time lag of the cross-correlation was 0 min in most subjects (13 out of 15) and at +IO min in the remaining two subjects. Sex steroids (Table II) . Mean P levels increased from 2.6±1.8 in the ELP to 19.4±6.4 ng/ml in the MLP (P < 0.01) and declined to 7.0±4.8 ng/ml in the LLP (NS between ELP and LLP, P < 0.05 between MLP and LLP). P secretion in the ELP was stable at a mean level of 1.0 and 6.2 ng/ml in subject A and B, respectively (Fig. 4) . No significant cross-correlation was present between LH and P or between FSH and P levels at any time lag in the ELP. The subjects studied during the MLP and LLP showed a remarkably different pattern of secretion. In the MLP (Fig. 5) , P levels fluctuated widely from levels as low as 4.1 ng/ml to peaks of40.1 ng/ml. In these two subjects, a positive cross-correlation between LH and P at time lag of 20-30 min (subject C) and 30-40 min (subject D) was present. A positive cross-correlation was also observed between FSH and P levels at time lags of 20-30 min (C) and 30 min (D creasing LH levels, as reflected by the change of P levels, was already present after 10-20 min. Mean plasma P levels in the LLP were 9.2 and 10.6 ng/ml for subjects E and F, respectively.
Similar to the MLP, marked plasma P variations were present over the 24-h study in the LLP with individual samples ranging between 2.3 and 27.2 ng/ml (Fig. 6 ). Cross-correlation analysis between LH and P levels provided significant results at 50-60 min and 30-50 min for subjects E and F, respectively, with initial P increments already present 10-20 min following the initiation of the LH pulses. FSH and P data series from the pulsation studies were also correlated in the LLP at time lags 30 min (E) and 20-30 min (F). Mean plasma E2 levels were 95±14 pg/ml in the ELP, 156±3 pg/ml in the MLP (P < 0.001), and 88±38 pg/ml in the LLP (NS between ELP and LLP, P < 0.02 between MLP and LLP). The mean plasma levels of E2 and P on the day of the 24-h study (five determinations) were highly correlated (r = 0.81, P < 0.001). E2 levels did not correlate with LH interpulse intervals nor with the mean amplitude of LH pulses. However, a positive correlation (r = 0.60, P < 0.05) existed between the incidence of LH pulses of smaller amplitude (<5 mIU/ml) and mean E2 levels. (3, 4) have indicated that the frequency of LH discharge is slower (about every 4 h) and that the amplitude of each pulse is larger in the luteal phase than in the follicular phase. Our study extends these observations and suggests a more complex interaction of sex steroid secretion and gonadotropin modulation during the luteal phase. A progressive slowing of the LH pulse frequency was noted across the luteal phase with the LH interpulse interval increasing from 99 min in the ELP to 173 min by the LLP. This change in LH pulse frequency was correlated with the day of the luteal phase when each subject was studied but not with the mean level of P on that day, suggesting that it was the duration of exposure to P and not its absolute level which produced this change. The possible mechanisms by which P may effect this slowing of LH pulse frequency are still unclear. P has been shown to act at the hypothalamic level by reducing the rate of episodic discharge of gonadotropin-releasing hormone (GnRH) (10). However, in intact model such as human subjects, the site of action of steroids on the hypothalamic-pituitary axis is difficult to define with such precision (1 1). Although a hypothalamic level of activity is likely for P, a concomitant effect ofP directly upon the pituitary is not precluded. Simultaneous measurements of hypothalamic GnRH via a push-pull system and peripheral plasma LH levels in the sheep (12) have demonstrated that episodic secretion of GnRH may not always be attended by the appearance of a subsequent episode ofLH secretion from the pituitary. Therefore, only limited conclusions regarding GnRH pulse frequency can be inferred from our study.
Our estimation of the extent of the slowing of the pulsatile release of LH in the luteal phase is less marked than previously reported (3, 4) . This difference can be ascribed to the new finding of several LH pulses of smaller amplitude (<5 mIU/ml) coexisting with larger LH pulsations during the same study (Fig.  2) . In fact, if only the larger LH pulses (>5 mIU/ml) are considered, the LH interpulse interval increased to 327 min in the MLP and 313 min in the LLP. The subtle differences in LH interpulse interval estimates between our study and that of previous reports (3, 4) probably results from the less frequent blood sampling utilized by previous investigators (15-20 min), the more limited periods of observation (6-8 h of sampling), and the fewer subjects studied. All of these factors may be possible sources of underestimation in the detection of smaller gonadotropin pulsations. Furthermore, Yen et al. (3) defined their LH pulses as increments in plasma levels >5 mIU/ml, therefore automatically eliminating small amplitude LH pulsations. Although the mean amplitude of LH pulses is also progressively reduced across the luteal phase, this change is not correlated with the day of the luteal phase nor with the mean PorE2 levels ofthat day. However, the mean LH pulse amplitude is heavily influenced by the occurrence of small (i.e., <5 mIU/ ml) amplitude pulsations. The incidence of these smaller pulsations is not random across the luteal phase, but reaches its maximum in the MLP and is significantly correlated with the mean P and E2 levels of the day of the 24-h study ( Fig. 1) T I ME the MLP, with 52% of LH pulses being <5 mIU/ml and 30% > 15 mIU/ml (Fig. 3) as indicated by the excellent (r = 0.81) correlation existing between E2 and P levels on the days of the 24-h study. The present study suggests therefore that the frequency and amplitude of LH pulsations are separately modulated as attested to by their independent changes across the luteal phase. LH frequency is significantly correlated with the day of the luteal phase, while the incidence of LH pulses of smaller amplitude is highest in the MLP in parallel with peak plasma P levels ( Figs. 1 and 3) . This discordancy in patterns may indicate that modifications in LH pulse frequency are due to chronic exposure to P, while alteration in LH pulse amplitude are influenced by acute changes in P levels. These results are compatible then with P having a hypothalamic effect upon frequency as well as an independent pituitary site of action which affects the amplitude of each GnRH-induced LH pulse.
The difficulty in the identification of episodic discharge of FSH has plagued most previous studies ofgonadotropin secretion in the menstrual cycle. The longer half-life of FSH (20) results in a more stable pattern of peripheral plasma levels of this glycoprotein. Consequently, the resulting small ratio between the amplitude of each discrete burst of FSH secretion and its mean circulating level is an obstacle to the recognition ofepisodic FSH secretion. Therefore, methods of pulse identification based upon increments from base line which exceed a preset threshold are of limited value in the separation of the FSH signal (i.e. a (21) and in the human female (22) . In our study, the use of cross-correlation analysis demonstrates a significant relationship between LH and FSH levels predominantly at a time lag of 0 min. The existence of this type ofcorrelation usually indicates that a common stimulatory event precedes the modification encountered in both data series (LH and FSH). Furthermore, a significant cross-correlation exists between FSH and P levels at a time lag of 20-30 min in the four subjects in the MLP and LLP. This latter phenomenon is likely to be an indirect consequence of the relationship between LH and FSH. Although the issue of FSH control is far from being solved, our findings confirm that LH and FSH are secreted simultaneously. As such they provide yet another line of indirect evidence that GnRH plays an essential role in the regulation of both gonadotropins. The existence of variable plasma levels of P in the luteal phase has previously been suggested in ewes (23, 24) (2 h ) are likely to have limited the identification of both the LH signal and the P response in this study. On the other hand, it is also possible that the sheep CL is less sensitive than that of the human to LH stimulation as indicated by the high LH dose required to elicit a significant P increment in this animal (27) . Recently, Backstrom et al. (26) increase in response to endogenous LH pulses in the ELP and MLP of the human female. These investigators studied five women in the ELP and MLP and two women in the LLP for 6 h. The P pulsations which they identified in the ELP and MLP, although apparently related in most cases (75%) to LH secretion, are of much smaller amplitude (2.0±0.4 ng/ml) than the very large P increments (up to 40 ng/ml) described in our series. Furthermore, no distinction in P secretion is made between the ELP and the MLP and the pattern of P in the LLP is not mentioned in this report. An intermittent pattern of LH stimulation of the CL may well be essential for its physiologic secretion of P in view of the observation that continuous LH infusion in the sheep is attended by a prompt increment of P secretion, following which P levels return to base line within 1 h, presumably secondary to desensitization of the CL by LH (27) . However, contradictory information exists in the literature as to the role of gonadotropins in the formation, support, and demise of the CL. In the subhuman primate, the affinity of LH receptors in the CL does not change across the luteal phase, while their number reaches a peak in the MLP and then declines (28) . However, changes in P secretion in the luteal phase precede any modification of LH receptor concentrations, suggesting a relative dissociation of P production from gonadotropin receptor stimulation. Similarly, administration of an LH antiserum to rabbits does not affect the CL if given in the ELP (29) . In primates, hCG (30) and GnRH analogue (31) administration in ELP (days 1-4 post-LH surge) do not cause changes in P levels. This apparent insensitivity of the early CL to LH is also suggested by our findings.
Both subjects studied in the ELP demonstrated no correlation between mean plasma LH and P levels and no apparent response of the CL to the large endogenous LH pulses (Fig. 4) . Another explanation for this finding, however, is that the proximity of LH pulsations in the ELP may cause partial "desensitization" of the CL. Alternatively, input of sufficiently frequent trophic stimuli could result in nearly continuous secretion of P from the CL and thus obscure a pulsatile pattern of P secretion. A similar phenomenon of LH pulse slowing unmasking episodic gonadal steroid secretion has been observed in males in whom fluoxymesterone induced a slowed LH frequency and resulted in the emergence of a one-to-one correspondence of LH pulses and episodic testosterone release from the Leydig cell (32).
In contradistinction to the ELP, administration of hCG to monkeys (30) and of GnRH (33) and its agonists (31) to women at later stages of the luteal phase causes prompt increments in plasma P concentrations. The appearance of CL sensitivity to gonadotropins in this part of the cycle is also demonstrated by the acquired CL responsiveness to endogenous LH pulsations observed in our subjects in the MLP and LLP (Figs. 5 and 6 ). High doses of GnRH and its agonistic analogues are capable 1645 Neuroendocrine Control of the Human Corpus Luteum 
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of disrupting CL function and causing premature luteolysis (31, 33) when administered during the MLP and LLP. On the other hand, the administration ofa GnRH antagonist to Rhesus monkeys in the LP does not seem to affect CL function in spite of a significant suppression of gonadotropin levels (2) .
In the four subjects we studied in the MLP and LLP, P levels demonstrated large fluctuations over the 24-h study period. Plasma P concentrations in the same 24-h period ranged from as low as 2.3 ng/ml to peaks of40.1 ng/ml. Although the average time lag between peak LH and P secretion, as shown by crosscorrelation analysis, ranged between 20 and 60 min, the response of P to LH increments was almost immediate and in good agreement with previous studies employing continuous LH infusions (27) . Thus, this pattern of P secretion closely reflects episodic LH release; however, LH pulses of similar amplitude in the same individual appear to be associated with differing P responses from their CL (Fig. 5) , particularly in the slope of the decay of the P peak. Moreover, discrete elevations of P levels were occasionally observed with an apparent lack of a previous LH pulsation (Fig. 5) . Such patterns may indicate that, at times, discrepancies may exist between the bioactivity of circulating LH and its immunoactivity, as measured by RIA. Consequently, the measurement of pulsatile P from the human CL may represent the "ultimate" homologous in vivo bioassay for LH. Alternatively, some vestige of CL autonomy could remain in the MLP and LLP and be represented by these "autonomous" episodes of P secretion without antecedent LH pulses.
The finding of rapidly fluctuating P levels in the MLP and LLP of normal subjects raises the question of the value of a single P estimation in the assessment of luteal phase function. Our results clearly indicate that mid-luteal P levels previously considered incompatible with an adequate luteal phase (34, 35) may be detected in the course of a normal luteal phase. Finally, the prompt and direct response of P to LH pulses in the MLP and LLP suggests that despite its partial autonomy from pituitary activity, the human CL requires intermittent stimulation of LH to fully express its endocrine potential.
